Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

RECCE-327 demonstrates encouraging preliminary antiviral activity against SARS-CoV-2

Nov. 12, 2020

Alectrona presents new quaternary amine compounds for infections

Nov. 12, 2020

Ono initiates phase III study of Foipan for COVID-19

Nov. 11, 2020

Preliminary phase I data for AT-301 nasal spray being developed for COVID-19

Nov. 11, 2020

Phase I data reported for Medicago's COVID-19 vaccine candidate

Nov. 11, 2020

Sorrento files IND for STI-2020 for treatment of COVID-19

Nov. 10, 2020

FDA issues EUA for Lilly's bamlanivimab to treat recently diagnosed COVID-19

Nov. 10, 2020

GlaxoSmithKline's RSVPreF3 candidate vaccine shows promising clinical results

Nov. 10, 2020

Aligos Therapeutics divulges new compounds for hepatitis

Nov. 10, 2020

Phase III interim analysis shows COVID-19 vaccine efficacy rate above 90% with BNT-162b2

Nov. 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.